Amandeep S. Sidhu

Overview

Amandeep (Aman) S. Sidhu is a partner in the Litigation practice group with substantial experience representing companies in high stakes disputes, including clients across the healthcare, life science and pharmaceutical industries. Aman’s commitment to client service and delivering results is reflected in his recent recognition as a “40 Under 40” by the Washington Business Journal, “DC Rising Star” by The National Law Journal, “Rising Star” by the Minority Corporate Counsel Association, and “Best Under 40” by the National Asian Pacific American Bar Association.

Repräsentative Mandate

Represents several national healthcare providers in internal and government investigations, compliance and regulatory counseling matters, and active state and federal litigation; current active clients include hospitals, health systems, health plans, medical practice groups, and companies focused on life sciences, telemedicine and pharmaceutical development
Represents the largest shipbuilding company in the United States in various regulatory matters, including FCPA compliance

Led cross-office and inter-departmental team representing leading life science company in multi-pronged investigation arising from the company’s production of cells used in medical research; investigations spanned several Senate and House committee investigations—including a House Select Panel investigation—as well as two state investigations; representation also included health regulatory guidance and coordination of parallel civil litigation
Defended a regional health system in an intervened qui tam matter that resulted in negotiating the settlement of FCA allegations constituting more than $1 billion in alleged damages in United States ex rel. Kunz v. Halifax Health, et al. (M.D. Florida 2014); also obtained summary judgment for Halifax Health for non-intervened FCA allegations representing more than $450 million in alleged damages for Anti-Kickback Statute, Stark Law and Medicare lack of medical necessity violation
Represented five hospitals and health systems around the United States responding to FCA allegations related to kyphoplasty (an orthopedic procedure) stemming from a sealed qui tam complaint filed in the Western District of New York
Actively represents several major regional hospital systems in Certificate of Need (CON) and other state regulatory matters in Virginia, Maryland and Washington, DC, including associated litigation
- Won the unprecedented reversal of a CON denial for The George Washington University Hospital in Washington, DC, to establish a kidney and pancreas transplant program
- Obtained CON and other regulatory approvals for American Hospice, the nation’s first hospice management company in the District of Columbia
- Gained regulatory approval for a record $1 billion renovation and expansion of Inova Fairfax Hospital, the largest hospital in Northern Virginia
- Achieved landmark CON exemption for Breast Care for Washington that allowed the organization to launch mammography services in Washington DC’s Ward 8, providing access to critical services for the District’s underserved population
Represented multiple healthcare management organizations in response to congressional inquiries that preceded the passage of the Patient Protection and Affordable Care Act in 2010
Achieved a settlement for a large agricultural cooperative in response to alleged violations of the Commodity Exchange Act in Anderson, et al. v. Dairy Farmers of America, Inc. (D. Minn.)
Serves as lead pro bono counsel for a campaign to ensure that observant Sikhs may freely serve in the US military, resulting in over 20 clients being granted landmark religious accommodations allowing them to serve in the US Army with distinction while maintaining their religious articles of faith; efforts in this eight-year campaign resulted in the US Army’s adoption of an historic new policy in January 2017 that substantially lifts the obstacles to Sikhs and other religious minorities seeking religious accommodations